Compounded GLP-1 by medication.
Every US telehealth program in our chart that prescribes compounded GLP-1, indexed by the specific compounded formulation. Useful if you already know whether you want compounded semaglutide or compounded tirzepatide and need to pick the program from there.
As of 2026, compounded GLP-1 prescribing has narrowed. The FDA removed semaglutide from its drug-shortage list in February 2025 and tirzepatide in October 2024. Many programs that once offered compounded have exited the category. The programs below are the ones that remain active. Cash-pay prices run from roughly $178 to $349 a month for semaglutide and $278 to $549 for tirzepatide. For pricing context across the full market, see the GLP-1 cost guide and the best compounded GLP-1 programs ranked list.
Compounded semaglutide
14 programs in our chart prescribes this.
Compounded tirzepatide
10 programs in our chart prescribes this.
Microdosed compounded semaglutide (Noom-branded protocol)
1 program in our chart prescribes this.
Legacy semaglutide patients only, new sign-ups closed
1 program in our chart prescribes this.
Compounded oral semaglutide troches
1 program in our chart prescribes this.
Sublingual semaglutide lozenges
1 program in our chart prescribes this.
Injectable compounded semaglutide
1 program in our chart prescribes this.
Compounded semaglutide (provider-dependent)
1 program in our chart prescribes this.
Compounded tirzepatide (provider-dependent)
1 program in our chart prescribes this.